Gastroparesis Treatment Products Market Insights, Global Outlook and Forecast 2022-2028
Gastroparesis Treatment Products Market Insights, Global Outlook and Forecast 2022-2028
Analysis of the Gastroparesis Treatment Products Market reveals emerging trends, consumer adoption rates, and competitive strategies among leading manufacturers worldwide.
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
During normal digestion, the stomach contracts to help break down food and move it into the small intestine. Gastroparesis disrupts the stomach’s contraction, which can interrupt digestion. Diabetes can cause gastroparesis due to its effects on the nervous system.
The latest research study released by Market IntelliX evaluates market size and forecasts of Gastroparesis Treatment Products in Global, including the following market information:
Global Gastroparesis Treatment Products Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Gastroparesis Treatment Products market was valued at 5822.8 million in 2021 and is projected to reach US$ 7677.4 million by 2028, at a CAGR of 4.0% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Drugs Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Gastroparesis Treatment Products include Sumitomo, Cadila Pharmaceuticals, Sanofi, Teva, Johnson & Johnson, Pfizer, Kyowa Kirin Pharmaceuticals, Hanmi Pharm and Ani Pharmaceuticals, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MI has surveyed the Gastroparesis Treatment Products companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Market Segmentations:
Global Gastroparesis Treatment Products Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Gastroparesis Treatment Products Market Segment Percentages, by Type, 2021 (%)
Drugs
Surgical Treatment Products
Global Gastroparesis Treatment Products Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Gastroparesis Treatment Products Market Segment Percentages, by Application, 2021 (%)
Hospital Pharmacies
Private Clinics
Drug Stores
E-Commerce
Global Gastroparesis Treatment Products Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Gastroparesis Treatment Products Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Gastroparesis Treatment Products revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Gastroparesis Treatment Products revenues share in global market, 2021 (%)
The report presents profiles of competitors in the market, Some of the prominent key players covered:
Sumitomo
Cadila Pharmaceuticals
Sanofi
Teva
Johnson & Johnson
Pfizer
Kyowa Kirin Pharmaceuticals
Hanmi Pharm
Ani Pharmaceuticals
Medtronic
Boston Scientific
Key Takeaways from this Report
Evaluate market potential through analyzing growth rates (CAGR %), Volume (Units) and Value ($M) data given at country level – for product types, end use applications and by different industry verticals.
Understand the different dynamics influencing the market – key driving factors, challenges and hidden opportunities.
Get in-depth insights on your competitor performance – market shares, strategies, financial benchmarking, product benchmarking, SWOT and more.
Analyze the sales and distribution channels across key geographies to improve top-line revenues.
Understand the industry supply chain with a deep-dive on the value augmentation at each step, in order to optimize value and bring efficiencies in your processes.
Get a quick outlook on the market entropy – M&A’s, deals, partnerships, product launches of all key players for the past 4 years.
Evaluate the supply-demand gaps, import-export statistics and regulatory landscape for more than top 20 countries globally for the market.
1 Introduction to Research & Analysis Reports
1.1 Gastroparesis Treatment Products Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Gastroparesis Treatment Products Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Gastroparesis Treatment Products Overall Market Size
2.1 Global Gastroparesis Treatment Products Market Size: 2021 VS 2028
2.2 Global Gastroparesis Treatment Products Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Gastroparesis Treatment Products Players in Global Market
3.2 Top Global Gastroparesis Treatment Products Companies Ranked by Revenue
3.3 Global Gastroparesis Treatment Products Revenue by Companies
3.4 Top 3 and Top 5 Gastroparesis Treatment Products Companies in Global Market, by Revenue in 2021
3.5 Global Companies Gastroparesis Treatment Products Product Type
3.6 Tier 1, Tier 2 and Tier 3 Gastroparesis Treatment Products Players in Global Market
3.6.1 List of Global Tier 1 Gastroparesis Treatment Products Companies
3.6.2 List of Global Tier 2 and Tier 3 Gastroparesis Treatment Products Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Gastroparesis Treatment Products Market Size Markets, 2021 & 2028
4.1.2 Drugs
4.1.3 Surgical Treatment Products
4.2 By Type - Global Gastroparesis Treatment Products Revenue & Forecasts
4.2.1 By Type - Global Gastroparesis Treatment Products Revenue, 2017-2022
4.2.2 By Type - Global Gastroparesis Treatment Products Revenue, 2023-2028
4.2.3 By Type - Global Gastroparesis Treatment Products Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Gastroparesis Treatment Products Market Size, 2021 & 2028
5.1.2 Hospital Pharmacies
5.1.3 Private Clinics
5.1.4 Drug Stores
5.1.5 E-Commerce
5.2 By Application - Global Gastroparesis Treatment Products Revenue & Forecasts
5.2.1 By Application - Global Gastroparesis Treatment Products Revenue, 2017-2022
5.2.2 By Application - Global Gastroparesis Treatment Products Revenue, 2023-2028
5.2.3 By Application - Global Gastroparesis Treatment Products Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Gastroparesis Treatment Products Market Size, 2021 & 2028
6.2 By Region - Global Gastroparesis Treatment Products Revenue & Forecasts
6.2.1 By Region - Global Gastroparesis Treatment Products Revenue, 2017-2022
6.2.2 By Region - Global Gastroparesis Treatment Products Revenue, 2023-2028
6.2.3 By Region - Global Gastroparesis Treatment Products Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Gastroparesis Treatment Products Revenue, 2017-2028
6.3.2 US Gastroparesis Treatment Products Market Size, 2017-2028
6.3.3 Canada Gastroparesis Treatment Products Market Size, 2017-2028
6.3.4 Mexico Gastroparesis Treatment Products Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Gastroparesis Treatment Products Revenue, 2017-2028
6.4.2 Germany Gastroparesis Treatment Products Market Size, 2017-2028
6.4.3 France Gastroparesis Treatment Products Market Size, 2017-2028
6.4.4 U.K. Gastroparesis Treatment Products Market Size, 2017-2028
6.4.5 Italy Gastroparesis Treatment Products Market Size, 2017-2028
6.4.6 Russia Gastroparesis Treatment Products Market Size, 2017-2028
6.4.7 Nordic Countries Gastroparesis Treatment Products Market Size, 2017-2028
6.4.8 Benelux Gastroparesis Treatment Products Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Gastroparesis Treatment Products Revenue, 2017-2028
6.5.2 China Gastroparesis Treatment Products Market Size, 2017-2028
6.5.3 Japan Gastroparesis Treatment Products Market Size, 2017-2028
6.5.4 South Korea Gastroparesis Treatment Products Market Size, 2017-2028
6.5.5 Southeast Asia Gastroparesis Treatment Products Market Size, 2017-2028
6.5.6 India Gastroparesis Treatment Products Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Gastroparesis Treatment Products Revenue, 2017-2028
6.6.2 Brazil Gastroparesis Treatment Products Market Size, 2017-2028
6.6.3 Argentina Gastroparesis Treatment Products Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Gastroparesis Treatment Products Revenue, 2017-2028
6.7.2 Turkey Gastroparesis Treatment Products Market Size, 2017-2028
6.7.3 Israel Gastroparesis Treatment Products Market Size, 2017-2028
6.7.4 Saudi Arabia Gastroparesis Treatment Products Market Size, 2017-2028
6.7.5 UAE Gastroparesis Treatment Products Market Size, 2017-2028
7 Players Profiles
7.1 Sumitomo
7.1.1 Sumitomo Corporate Summary
7.1.2 Sumitomo Business Overview
7.1.3 Sumitomo Gastroparesis Treatment Products Major Product Offerings
7.1.4 Sumitomo Gastroparesis Treatment Products Revenue in Global Market (2017-2022)
7.1.5 Sumitomo Key News
7.2 Cadila Pharmaceuticals
7.2.1 Cadila Pharmaceuticals Corporate Summary
7.2.2 Cadila Pharmaceuticals Business Overview
7.2.3 Cadila Pharmaceuticals Gastroparesis Treatment Products Major Product Offerings
7.2.4 Cadila Pharmaceuticals Gastroparesis Treatment Products Revenue in Global Market (2017-2022)
7.2.5 Cadila Pharmaceuticals Key News
7.3 Sanofi
7.3.1 Sanofi Corporate Summary
7.3.2 Sanofi Business Overview
7.3.3 Sanofi Gastroparesis Treatment Products Major Product Offerings
7.3.4 Sanofi Gastroparesis Treatment Products Revenue in Global Market (2017-2022)
7.3.5 Sanofi Key News
7.4 Teva
7.4.1 Teva Corporate Summary
7.4.2 Teva Business Overview
7.4.3 Teva Gastroparesis Treatment Products Major Product Offerings
7.4.4 Teva Gastroparesis Treatment Products Revenue in Global Market (2017-2022)
7.4.5 Teva Key News
7.5 Johnson & Johnson
7.5.1 Johnson & Johnson Corporate Summary
7.5.2 Johnson & Johnson Business Overview
7.5.3 Johnson & Johnson Gastroparesis Treatment Products Major Product Offerings
7.5.4 Johnson & Johnson Gastroparesis Treatment Products Revenue in Global Market (2017-2022)
7.5.5 Johnson & Johnson Key News
7.6 Pfizer
7.6.1 Pfizer Corporate Summary
7.6.2 Pfizer Business Overview
7.6.3 Pfizer Gastroparesis Treatment Products Major Product Offerings
7.6.4 Pfizer Gastroparesis Treatment Products Revenue in Global Market (2017-2022)
7.6.5 Pfizer Key News
7.7 Kyowa Kirin Pharmaceuticals
7.7.1 Kyowa Kirin Pharmaceuticals Corporate Summary
7.7.2 Kyowa Kirin Pharmaceuticals Business Overview
7.7.3 Kyowa Kirin Pharmaceuticals Gastroparesis Treatment Products Major Product Offerings
7.7.4 Kyowa Kirin Pharmaceuticals Gastroparesis Treatment Products Revenue in Global Market (2017-2022)
7.7.5 Kyowa Kirin Pharmaceuticals Key News
7.8 Hanmi Pharm
7.8.1 Hanmi Pharm Corporate Summary
7.8.2 Hanmi Pharm Business Overview
7.8.3 Hanmi Pharm Gastroparesis Treatment Products Major Product Offerings
7.8.4 Hanmi Pharm Gastroparesis Treatment Products Revenue in Global Market (2017-2022)
7.8.5 Hanmi Pharm Key News
7.9 Ani Pharmaceuticals
7.9.1 Ani Pharmaceuticals Corporate Summary
7.9.2 Ani Pharmaceuticals Business Overview
7.9.3 Ani Pharmaceuticals Gastroparesis Treatment Products Major Product Offerings
7.9.4 Ani Pharmaceuticals Gastroparesis Treatment Products Revenue in Global Market (2017-2022)
7.9.5 Ani Pharmaceuticals Key News
7.10 Medtronic
7.10.1 Medtronic Corporate Summary
7.10.2 Medtronic Business Overview
7.10.3 Medtronic Gastroparesis Treatment Products Major Product Offerings
7.10.4 Medtronic Gastroparesis Treatment Products Revenue in Global Market (2017-2022)
7.10.5 Medtronic Key News
7.11 Boston Scientific
7.11.1 Boston Scientific Corporate Summary
7.11.2 Boston Scientific Business Overview
7.11.3 Boston Scientific Gastroparesis Treatment Products Major Product Offerings
7.11.4 Boston Scientific Gastroparesis Treatment Products Revenue in Global Market (2017-2022)
7.11.5 Boston Scientific Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
Research Methodology:
Gastroparesis Treatment Products Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|